Clinical Trials
AKos is coordinator of several clinical trials in rare hereditary disease research| sifap1 |
(Stroke in Young Fabry Patients) Frequency of Fabry Disease in Young Stroke Patients |
 |
| sifap2 | (Stroke in Young Fabry Patients) Characterization of the Stroke Rehabilitation |
|
| FASEP | (Fabry and Stroke Epidemiological Protocol) Risk Factors In Ischemic Stroke Patients With Fabry Disease |
 |
| PadGau | Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation |  |
| SWITCH | The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease |  |
| MS+Fabry | Prevalence of Fabry Disease in a Defined Population at Risk Patients Formerly Diagnosed With Multiple Sclerosis | |
| BioGaucher | Biomarker for Gaucher Disease - An International, Multicenter, Epidemiological Protocol |
 |
| BioHunter |
Biomarker for Hunter Disease - An International, Multicenter, Epidemiological Protocol |
 |
| BioKrabbe |
Biomarker for Krabbe Disease - An International, Multicenter, Epidemiological Protocol |
 |
| BioMaroteaux |
Biomarker for Maroteaux-Lamy Disease - An International, Multicenter, Epidemiological Protocol |
 |
| BioMeta |
BioMarker for Metachromatic Leukodystrophy - An International, Multicenter, Epidemiological Protocol |
 |
| BioMorquio |
Biomarker for Morquio Disease - An International, Multicenter, Epidemiological Protocol |
 |
| BioNPC | Biomarker for Niemann Pick Type C Disease - An International, Multicenter, Epidemiological Protocol |
 |
| BioPompe |
Biomarker for Pompe Disease - An International, Multicenter, Epidemiological Protocol |
 |
